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Abstract 
Background: Diabetes mellitus is the most prevalent metabolic 
disorder. Previous related studies have shown that, lungs are target 
organs in diabetic micro-angiopathy. The present study was designed 
to investigate the spirometric indices in patients with type 2 diabetes 
referred to the outpatient clinic of Imam Hussein hospital in Shahroud, 
Iran. 
Methods: This comparative study included 50 patients with type 2 
diabetes and 50 non-diabetic subjects who were matched in terms of 
weight, age, and sex, and were referred to the Diabetes clinic of Imam 
Hussein hospital in Shahroud, Iran. MIR SPIROLAB III spirometer 
was used for spirometric tests to obtain FEV1, FVC, PEFR, and FEF 
25-75. Decrease in these indices is determinant of pulmonary 
complications. Indices were compared between two groups. The 
relationships between some variables like glycated hemoglobin 
(HbA1c) and type of their treatment with the severity of spirometric 
disturbances were also assessed. 
Results: The average age was equal to 56.3 years old (with SD of 6.3 
years) and 58.3 years old (with SD of 6.3 years), respectively in non-
diabetic and diabetic group. Comparison of the FEV1, FVC, PEFR, 
and FEF 25-75 indices between diabetic and non-diabetic groups 
showed a significant difference (P.V<0.05). No significant difference 
was found in the FEV1/FVC ratio. According to the Pearson 
correlation formula, there was a significant association between 
decreased spirometric indices and increased concentration of Hb A1C 
(-.630, -.635 and-.374 for FEV1, FVC, and PEFR, respectively). There 
was no association between decreased concentration of FEV1/FVC 
and increased HbA1c. 
Conclusions: The findings of the study revealed that, there was a 
significant decrease in pulmonary functions in the diabetic group. 
Impaired pulmonary function can be detected in early stages of 
diabetes and studying the pulmonary function can be easily preformed. 
Accordingly, screening lungs function should be carried out regularly, 
as well as integrating in other routine examinations and screening 
tests. 
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Introduction 
Diabetes mellitus is the most prevalent metabolic disorder, 
and is also a common chronic disease worldwide. It can be 
presented with different manifestations among all races.1 
According to the WHO, diabetes is a chronic multifactorial 
metabolic disorder characterized by an impairment in 
carbohydrate, lipid ,and protein metabolism due to the defects 
in either insulin production or its decreased function.2 Type 2 or 
Non-Insulin-Dependent Diabetes Mellitus (NIDDM) is 
presented by impaired insulin receptors and insulin resistance. 
NIDDM is a common type of diabetes, in which there is no 
aberration in B cells function and develops after the age of 40. 
During the late decades, several epidemiological studies on the 
prevalence of type 2 diabetes have been performed in Iran. 
Studies have shown that, the prevalence of diabetes among>30 
people, is between 6.5 to 10.6% (approximately 2.4 million 
people in the population of Iran in 2010). Moreover, 14.5 to 
22.5% of >50 people are affected by the Impaired Glucose 
Tolerance (IGT).1 Hyperglycemia is presented by the polyuria, 
polydipsia and weight loss. Notably, increased appetite and 
blurred vision have also been documented. 
Long-lasting diabetes complications result from macro and 
micro vascular injuries involving the diabetic retinopathy with 
the potential risk of blindness, progressive nephropathy with 
the risk of renal failure, peripheral neuropathy with the risk of 
diabetic foot ulcer, limb amputation, Charcot joint and 
autonomic neuropathy inducing the digestive, cardiovascular, 
urogenital and sexual complications.3 
A considerable number of studies have introduced the lung 
as a target organ in diabetic micro-angiopathies. 
Histopathology results showed the increased thickness and 
fibrosis of basal membrane. Presence of an abundant amount of 
connective tissue and an extensive microvascular circulation 
increase the possibility of lungs involvement in micro-angio-
pathies and non-enzymatic glycosylation of tissue proteins.4,5 
Normal pulmonary mechanics and its alveolar exchange is 
influenced by the integrity of connective tissue and pulmonary 
micro-vascularization. Any perturbation in the system leads to 
the development of disorders in the Pulmonary Function Tests 
(PFTs).6 
On the other hand, diabetes increases the concentration of 
inflammation mediators and biomarkers. The increase in the 
inflammatory cytokine, in association with micro-angiopathies 
can change the proteins in the matrix of pulmonary tissue.7 
Pulmonary mechanics disorders are divided into 
obstructive and restrictive disorders. Obstructive pulmonary 
diseases are characterized by the airway obstruction caused by 
the constriction of lower airways. In spirometry, the decrease in 
the exhalation rate results from the obstruction. Consequently, 
the decrease in Forced Expiratory Volume in 1 second (FEV1) 
is more than the Forced Vital Capacity (FVC0). Therefore, 
FEV1/FVC ratio decreases. In the condition, where the 
FEV1/FVC ratio is lesser than 30% of the normal condition, 
obstructive pulmonary disease is diagnosed. FEV1/FVC ratio 
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can also act as a criterion for differential diagnosis between 
obstructive and restrictive pulmonary diseases. It is now 
understood that, extra-pulmonary, plural or parenchymal 
factors can influence on the normal pulmonary stretch and 
result in the respiratory overload and inadequate oxygenation. 
The decreased pulmonary capacity (except FEV1/FVC ratio) 
occurs as a result of the decrease in the total pulmonary 
capacity.8 While most of the studies have concluded that, the 
pattern of spirometric disorders in diabetic patients are similar 
to the restrictive diseases,2-12 some of them demonstrated the 
obstructive pattern.13 Hence, this study was carried out to assess 
the spirometric indices (FEV1, FVC, PEFR, FEF 25-75 and 
FEV1/FVC) in patients with type 2 diabetes referred to Imam 
Hussein hospital, Shahroud, Iran (2016-2017). 
Materials and Methods  
This comparative study designed for fulfillment of a MD 
thesis (with a research code of 180 at Shahroud University of 
Medical Sciences) included 50 patients with NIDDM referred 
to the Diabetes clinic of Imam Hussein hospital from 2016 to 
2017. In addition, 50 weight -and sex- matched normo-
glycemic subjects were included as the control group. 
Determination of sample size was based on the study by 
Anandhalakshmi considering the difference between FVC of 
diabetic and control group (d=0.53) and variance of 2=4σ with 
confidence level of 5% and power of 80%. Based on these data, 
the primary sample size was obtained as 22 for each group; but 
to eliminate the probable errors, it increased to 50 for each 
group. The control group was selected from the healthy 
individuals such as patients ̓accompaniment, patient’s relatives, 
the stuff of Imam Hussein hospital or even the patients needed 
minor surgeries. An informed consent was taken from all the 
subjects (research code 180). 
Inclusion criteria included previously diagnosed diabetic 
cases or the patients who were recently diagnosed with diabetes 
based on the American Diabetes Association criteria 
(FBS>126). Exclusion criteria (In both diabetic and non-
diabetic groups) included history of severe or chronic 
pulmonary disease, observable abnormalities in vertebral 
column and rib cage (for example kyphoscoliosis), 
uncontrolled pulmonary and cardiac disorders, neuro-muscular 
disorders, malignancies, patients who recently had a major 
abdominal or thoracic surgery, addiction, any kind of tobacco 
smoking either currently or in the past, pregnancy and patients 
with ascites and abdominal tumors.  
Spirometry was performed for both groups by a single 
skilled technician using the MIR SPIROLAB III spirometer. 
Before preforming spirometry, the information of the patients 
was written on an identification paper and weight and height 
were measured and entered into the instrument. All the patients 
sat on a chair while their soles were on the ground. To remove 
the pressures from their lungs, they took off any of their tight 
clothes. After putting the clips on their nose, they took several 
normal inhalation and exhalation. Then, they took a deep fast 
breath so that, the whole lungs becomes full of air. After that, 
they exhaled with all intensity and strength so that, the lungs 
become empty, and the exhalation lasted for about 6 seconds. 
Forced Expiratory Volume in 1 second (FEV1), Forced 
Vital Capacity (FVC), Forced Expiratory Volume Percentage 
(FEV1 /FVC), Peak Expiratory Flow Rate (PEFR), and Forced 
Expiratory Flow (FEF) (25–75%) were used as respiratory 
indices. These indices can be used as diagnostic criteria in early 
stages of obstruction in lower respiratory tract. 
To prevent any measurement variations, the spirometry was 
performed between 9 am to 1 pm (before having meal) on all 
patients. Patients should not have eaten a heavy meal before the 
test. The test was carried out in the sitting posture and the 
subjects performed the test 3 times at an interval of 15 minutes. 
The results of the tests were compared and the best functions 
were selected and reported. Notably, the test was carried out for 
all the patients by the same technician. 
From the point of view of disease control, the diabetic 
patients were classified into two groups of patients with greater 
than 7 and lesser than 7 HbA1c concentration14 and then they 
were compared to each other. Based on the type of treatment, 
the patients were categorized into the group who received 
insulin and the group who underwent anti-diabetic medication. 
To analyze the collected data, SPSS software version 20 was 
used at a significance level of 0.5%. To compare spirometric 
indices between the diabetic and non-diabetic groups, 
Independent Samples T-Test was used and to study the 
association between pulmonary indices and HbA1c, Pearson 
correlation coefficient was recruited for evaluating the 
correlation between glycosylated hemoglobin and spirometric 
indices (FEV1, FVC.PEFR, FEF25-75 and FEV1/FVC). 
Results 
Totally, 50 diabetic patients and 50 non-diabetic subjects 
were studied as the diabetic and non-diabetic groups, 
respectively. In the diabetic group, 50 patients were included 
with the mean age of 58.3±6.3 years old (median of 59 years 
old, age range between 43 and 69 years old). In the control 
group, 50 individuals were involved with the mean age of 
56.3±6.3 years old (median of 57 years old, age range between 
43 and 68 years old). There were significant differences in the 
FEV1, FVC, PEFR and FEF25-75 (P< 0.05) between the 
diabetic and non-diabetic groups. However, there was no 
significant difference in the FEV1/FVC ratio between the 
diabetic and non-diabetic groups. (Table1). 
Table 1. The association between spirometric indices in 
diabetic and non-diabetic groups 
Table 1. The association between spiro-metric indexes in diabetic and 
non-diabetic groups 
P.V Standard Deviation Mean Group Variable 
٠٫٠٠٢ 
١٥٫٢ ۸۲ᡡ۳ Diabetic 
(Predicted %) FEV1 
٩٫٤ ٩٠٫٤ Non-diabetic 
٠٫٠٠ ١٤٫٦ ٨٠٫٧ Diabetic (Predicted %) FVC 
٨٫٦ ٩٠٫٥ Non- diabetic 
٠٫٠٠ ١٤٫٤ ٧٥٫٤ Diabetic (Predicted %) PEFR 
٦٫٨ ٨٦ Non- diabetic 
٠٫٠٠٢ ١٧٫٥ ٧١٫٩ Diabetic (Predicted %) FEF25-75 
١٣٫٩ ٨٢٫١ Non- diabetic 
٠٫٢٣٠ ٧٫٩ ٨٠٫٧ Diabetic FEV1/FVC 
٦٫٤ ٨٢٫٤ Non- diabetic 
According to the Pearson correlation coefficient, there was 
a significant relationship between the decrease in the 
spirometric indices (FEV1, FVC, PEFR and FEF 25-75) and 
increased Hb A1C. Though, no significant difference was 
found between decreased FEV1/FVC and increased Hb A1C. 
(Table2). 
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Table 2. The association between spiro-metric indexes and glycosylated hemoglobin 
FEV1/FVC  FEF25-75  PEFR  FVC  FEV1  Variable  
HbA1c  -٠٫٢٥٠  -٠٫٦٤٠  -٠٫٣٧٤  -٠٫٦٣٥  -۰ᡡ۶۳۰  and Pearson correlation coefficient  
٠٫٠٠٠  ٠٫٨٠  ٠٫٠٠٧  ٠٫٠٠٠  ٠٫٠٠٠  P.V 
 
Table 2.The association between spirometric indices and 
glycosylated hemoglobin  
FEV1, FVC, FEF 25-75 parameters showed significant 
differences with low HbA1c and HbA1c greater than 7 between 
two groups. But no significant difference was observed in 
relation to PEFR parameter and FEV1/FVC ratio between two 
groups. (Table3) 
Table 3. Comparison of spirometric indices between the 
diabetic groups with HbA1c>=7 and HbA1c<7 
Table 3. Comparison of spirometric indexes between the diabetic and 
non-diabetic groups with HbA1c>=7 and HbA1c<7 
P.V Standard Deviation  Mean  Number  HbA1c Index  
٠࿿٠٠٢  ١۴࿿۵٩  ٧٧٫٣٤  ٣۵  =<٧  FEV1  
٩࿿٠٠  ٩۴࿿١٣  ١۵  >٧  
٠࿿٠٠  ١٢࿿۵٢  ٧۵࿿٢٢  ٣۵  =<٧  FVC  
١٠࿿٨٢  ٩٣࿿۵٣  ١۵  >٧  
٠࿿١٧۶  ٨࿿٣۶  ٧٩࿿٧۴  ٣۵  =<٧  FEV1/FVC  
۶࿿۴١  ٨٣࿿٠۶  ١۵  >٧  
٠࿿٢۶١  ١٣࿿٢٨  ٧٣࿿٨٨  ٣۵  =<٧  PEFR  
١۶࿿٧٢  ٧٨࿿٩٣  ١۵  >٧  
٠࿿٠٠٢  ١۶࿿٧١  ۶٧࿿٠٠  ٣۵  =<٧  FEF25-75  
١٣࿿٨٠  ٨٣࿿۵٣  ١۵  >٧  
There was no significant difference between two treatment 
types (treatment with insulin and anti-diabetic medication) and 
the severity of spirometric abnormalities was evident. (Table 4) 
Table 4. Comparison between the insulin treatment and 
anti-diabetic medication group. 
Table 4. Comparison between the insulin treatment and anti-diabetic medication 
group 
P.V Standard Deviation  Mean  Number  Treatment Type Index  
۰ᡡ۸
٧  
۱۵ᡡ۹۵  ٨٣٫٠٠  ۳۷  anti-diabetic drugs  FEV1  
۱۳ᡡ۴۳  ۸۲ᡡ۱۶  ۱۳  Insulin  
۰ᡡ۳
۶  
۱۵ᡡ۱۳  ۸۱ᡡ۸۶  ۳۷  anti-diabetic  FVC  
۱۳ᡡ۰۹  ۷۷ᡡ۴۶  ۱۳  Insulin  
۰ᡡ۶
۲  
۶ᡡ۵۰  ۸۱ᡡ۶۹  ۳۷  anti-diabetic  FEV1/FVC  
۱۱ᡡ۲۸  ۸۰ᡡ۴۰  ۱۳  Insulin  
۰ᡡ۵
۵  
۱۵ᡡ۳۰  ۷۳ᡡ۳۰  ۳۷  anti-diabetic  PEFR  
۱۱ᡡ۷۹  ۷۶ᡡ۱۳  ۱۳  Insulin  
۰ᡡ۸
۴  
۱۷ᡡ۶۵  ۷۱ᡡ۰۷  ۳۷  anti-diabetic  
FEF25-75  
۱۷ᡡ۸۲  ۷۲ᡡ۲۷  ۱۳  Insulin  
Discussion 
The comparison between diabetic and non-diabetic groups 
showed a significant decrease in the FEV1, FVC, PEFR and 
FEF25-75 indices in the diabetic patients (P.V<0.05). Though, 
the FEV1/FVC ratio (decrease in this ratio represents 
obstructive diseases) did not reveal any significant difference. 
These results were consistent with the findings of the studies by 
Malek et al,3 Abdolazim et al9 also reported the same 
significant results in pulmonary parameters without a decrease 
in the FEV1/FVC ratio. Although, Serikant et al13 and Sheravia 
kerti 2 reported a significant decrease in this ratio. 
The pathophysiology of the decreased pulmonary function 
is not completely understood. Normal pulmonary mechanics 
and gas exchange are influenced by the composition of 
connective tissue and tiny pulmonary vessels. Accelerating 
aging process in cross linkage of the cells of connective tissue 
and the presence of non-enzymatic glycosylation and alteration 
in surfactant  function causes the lung function disorders.10 
Sandler et al studied the lungs by electron-microscope. 
Microscopic studies revealed thickening of the alveolar 
epithelium, endothelium capillary, and basal membrane in the 
diabetic patients. Also, they documented a decrease in the 
blood flow attributing to the micro-angiopathy.11 Thorax and 
lungs are rich in elastin and collagen. The decrease in the 
flexibility of thorax and pulmonary parenchyma results from 
non-enzymatic glycosylation of these structures.9 Our results 
showed a decrease in the pulmonary parameters in the diabetic 
group which are compatible with these pathologic findings. 
Furthermore, similar studies have shown the diabetic poly-
neuropathy leading to pulmonary neuro-muscular and 
consequently a decreased lung capacity.12 
It can be concluded that, there is an obvious decreased 
pulmonary function in the diabetic group. Because of no 
significant change in the FEV1/FVC ratio, this decrease in the 
capacity is assumed to be alarming. To confirm the extent of 
danger in relation to the decreased capacity, plethysmography 
should be performed. In this study, there was a significant 
association between spirometric indices-related disorders and 
increased BMI or the type of treatment. According to the mild 
to moderate association between the decrease in the spirometric 
indices and the increase in the glycosylated hemoglobin, it can 
be concluded that, there was a direct association between 
uncontrolled diabetes and pulmonary function disorder. 
Patients̓ lack of awareness about their duration of disease 
could be considered as the first limitations of this study, so 
there was no possibility to assess the relationship between the 
duration of the disease and severity of the spirometrical 
disturbances. The use of spirometer instead of plethysmograph 
was the second limitation, as it is able to measure more 
volume-related indices such as total lung capacity and is also 
able to confirm the diagnosis of restrictive diseases, 
highlighting the need for further studies. Considering 
incompatible results of different studies, further prospective 
studies with greater sample size are required. In the future 
studies, the measurement of concentration of glycosylated 
hemoglobin and spirometric indices should be repeated at 
particular intervals and they should be compared with each 
other. So, it can be concluded that, the lung is a target organ in 
diabetes and hyperglycemia is a potential determinant in the 
decreased pulmonary function in diabetic patients. Therefore, 
monitoring the concentration of blood sugar can improve 
respiratory function. As reported in the study by Aprana et al., 
decreased lung capacity is an early manifestation of diabetes 
and can be easily diagnosed by examining the pulmonary 
function. Therefore, performing the pulmonary function test 
along with other routine tests and examinations is highly 
recommended. 
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